Drug repurposing consists of finding new uses for existing medicines.

Discover what drug repurposing is and why it is important in the video below.

Discover More: Drug repurposing involves using medicines approved for one disease to treat another. Find out more about the process and explore real-life examples here.

Potentially Faster, Cheaper Solutions: Repurposed drugs often reach patients quicker and at a lower cost compared to traditional drug discovery methods. For diseases lacking existing medicines, they might be the best chance of getting a treatment.

Patients First: At REMEDi4ALL we’re putting patients at the heart of research. We champion the idea that the best treatments are those made by and with the people who use them – not just for them.

Patient-Driven Initiatives: Patients are the driving force behind all our drug repurposing initiatives. They bring unique insights and lived experience to the heart of research.

Patient Champions: We involve patients at every stage by partnering with a dedicated patient champion – someone with first-hand experience of the disease. Together, they work with researchers in the drug development team to find innovative solutions.

Empowering Activities: Collaboratively, we create patient advocacy groups and engagement plans. Tailored activities, such as buddy systems for clinical trials, focus groups for product design, multi-stakeholder meetings and bootcamps unite researchers and patients.

Dedicated Training: The REMEDi4ALL Digital Academy is an accessible online learning hub which describes the entire drug repurposing pathway. Whether you are new to drug repurposing or looking to develop your knowledge in a specific aspect of drug repurposing, you can find easy-to-understand resources here.

We want to hear from you! Contact us to discover ongoing projects in your area and get matched to exciting opportunities.

Stay tuned for the latest updates, news, and opportunities in the field of drug repurposing via the REMEDi4ALL newsletter and on social media (LinkedIn, X, Bluesky and Facebook).